1.Kirazov, E.P., Michelakakis H. and Lagnado J.R.: Microtubule Associated
Phospholipids. 2nd International Colloquium on Physical and Chemical Information
Transfer in Regulation of Reproduction and Ageing, Varna, 1977.

2. Michelakakis, H. and Danpure C.J.: The Effect of Cytochalasin B on the Release
of Lysosomal Enzymes from Isolated Rat Hepatocytes. 584th Meeting of the
Biochemical Society, England 1979.

3. Michelakakis H. and Danpure C.J. : The Uptake and Release of Lysosomal
Enzymes by Isolated Perfused Rat Livers. 590th Meeting of the Biochemical
Society, England 1980.

4. Michelakakis H. and Danpure C.J.: Effect of Cytochalasin B on the Release of
Lysosomal Enzymes and Preloaded 125I-PVP from Isolated Perfused Rat Liver.
2nd International Congress on Cell Biology, W. Berlin 1980.

5. Michelakakis, H. and Danpure C.J. : Effect of Cytochalasin B on the Release of
Lysosomal Enzymes from Isolated Perfused Rat Liver. British Soc. of Cell Biology,
Liverpool 1980.

6. Michelakakis H. and Danpure C.J. : The effect of intralysosomally-stored
macromolecules on the cytochalasin B induced release of lysosomal enzymes by
isolated perfused rat liver. 16th Hardeen Conference, Wye 1980.

7. Michelakakis H. and Danpure C.J.: The Effect of Microfilament Disruption on the
Exocytosis of Lysosomal Enzymes and Intralysosomally Stored Non-Degradable
Macromolecules in Isolated Perfused Rat Liver. 2nd Clinical Research Centre
Symposium on the Treatment of Inborn Errors of Metabolism, London 1981.

8. Michelakakis H. and Micheloyanis J. : Biochemical findings at different time
points of valproate treatment. 4th International Child Neurology Congress.
Jerusalem, March 1986.

9. Lambadaridis J., Costalos Ch., Sevastiadou S.,Thalassinos A. and Michelakakis
H.: Plasma and cerebrospinal fluid amino acids in neonates with perinatal anoxia.
26th Annual SSIEM Meeting, Glasgow, September 1988.

10. Michelakakis H., Tsagaraki S., Dimitriou E., Soulpis K.,Giouroukos S.: Lysosomal
Storage Diseases in Greece. Laboratory Experience. 26th Annual SSIEM Meeting,
Glasgow, September 1988.

11. Michelakakis H., Dimitriou E., Bartsocas Ch., Skardoutsou A., Giouroukos S.:
Metachromatic Leukodystrophy in Greece. 5th International Clinical Genetics
Seminar, Rethymno, October 1988.

12. Michelakakis H., Georgakis H., Dimitriou E., Psilla M., Malliarou A., Karaklis A.,
Bastis-Maounis B., Kousparou M., Karagiorga-Lagana M. : Enzymuria in
Thalassemic Patients. International Congress on Thalassemia, Sardinia, April
1989.

13. Dimitriou E. and Michelakakis H. : Metachromatic Leukodystrophy: The 0° degree
assay of white blood cell arylsulphatase A. 22nd Annual Symposium of the
European Society of Human Genetics, Corfu, May 1990.

14. Michelakakis H., Psilla M., Dimitriou E.: Primary and secondary biochemical
findings in Gaucher’s disease. 22nd Annual Symposium of the European Society of
Human Genetics, Corfu, May 1990.

15. Anagnostakou-Koukoudaki M., Michelakakis H., Skouroliakou M.,Sarafidou G.,
Thalassinos A., Papagaroufalis C.,Xanthou M.: Parenteral nutrition and serum
amino acids in premature neonates. XIIth Europ. Congress of Perinatal Medicine,
Lyon 1990.

16. Giouroukos S., Katsarou E., Divry P., Michelakakis H., Rolland M.O and
Skardoutsou A.: N-Acetylaspartate levels and aspartoacylase activity in Canavan’s
disease. ΧΙΧ Meeting of the Middle Eastern and Mediterranean Pediatrics
Societies, Athens 1990.

17. Michelakakis H., Giouroukos S.,Dimitriou E., Tsagarakis S.,Soulpis K., Bartsokas
Ch.: Lysosomal storage diseases in Greece:Nine years of laboratory experience.
ΧΙΧ Meeting of the Middle Eastern and Mediterranean Pediatrics Societies, Athens
1990.

18. Youroukos S., Dimitriou E., Michelakakis H. : Sphingolipidoses in Greece. 18
Reunion Societe Europeenne de Neurologie Pediatrique, December 1990.

19. Stephanidis C.J., Klavdianou M., Papagaroufalis C., Michelakakis H., Xanthou M.:
Peritoneal dialysis in very low birth weight infants. International Workshop of
Neonatal Nephrology, Rome, May 1991.

20. Michelakakis H., Papadimitriou A., Divaris R., Photidou A., Mavridou I., Dimitriou
E.: Plasma Lysosomal Enzyme Levels in Patients with Motor Neuron Disease. 29 th
Annual SSIEM Symposium, London, September 1991.

21. Mylona-Karayanni Ch., Michelakakis H., Dimitriou E., and Bartsocas Ch:
Mannosidosis Type II: Report of two cases. 29th Annual SSIEM Symposium,
London, September 1991.

22. Michelakakis H., Delis D., Anastasiadou V. and Bartsocas Ch.: Effect of captopril
on cystine excretion in cystinuric children. 29th Annual SSIEM Symposium,
London, September 1991.

23. Michelakakis H., Dimitriou E., Georgakis H., Karabatsos F., Premetis E.,
Karagiorga-Lagana M.: Lysosomes in β-Thalassemia Major. 8th Workshop of the
European Study Group on Lysosomal Diseases, Annecy, October 1991.

24. Stefanidis C.J., Michelakakis H., Kapogiannis A., Kousta H., Koulieri A., Michelis
K.: Nutritional status and growth of children less than 12 kg treated with CAPD. VIth
Congress of the Int. Soc. Peritoneal Dialysis, Thessaloniki, October 1992.

25. Michelakakis H., Lambadaridis J., Pataki H., Mavridou I., Alexiou N., Pavlidou D.,
Thalassinos A., Costalos Ch.: Carnitine and MCT supplementation in small for
dates premature neonates. XIIIth European Congress of Perinatal Medicine,
Amsterdam, May 1992.

26. Lambadaridis J., Michelakakis H., Thalassinos A., Costalos Ch.: The effect of
perinatal anoxia on serum and CSF amino acids of premature small for dates
neonates. XIIIth European Congress of Perinatal Medicine, Amsterdam, May 1992.

27. Michelakakis H., Lambadaridis J., Thalassinos A., Costalos C.: Serum and CSF
amino acids in perinatal anoxia. 30th Annual SSIEM Symposium, Leuven,
September 1992.

28. Skardoutsou A., Michelakakis H., Divry P., Christensen E., Schulpis K.: Glutaric
Aciduria type I: report of two cases. 30th Annual SSIEM Symposium, Leuven,
September 1992.

29. Trivli V., Delis D., Michelakakis H., Zabot M.T., Dumoulin R., Bartsocas C.: A
thiamine responsive case of maple syrup urine disease. 30th Annual SSIEM
Symposium, Leuven, September 1992.

30. Papadimitriou A., Michelakakis H., Divari E., Frangos P., Jacobs C., Divry P.:
Encephalopathy associated with 2-hydroxy Glutaric Aciduria. XVth World Congress
of Neurology, Vancouver, September 1993.

31. Dimitriou E. and Michelakakis H.: Biochemical Studies on Gaucher Disease. 9 th
ESGLD Workshop, Delphi, October 1993 and 1st Balkan Meeting of Human
Genetics, Thessaloniki, September 1994.

32. Mavridou E., Pataki H., Young E. and Michelakakis H.: β-Galactosidase
deficiency: biochemical studies. 9th ESGLD Workshop, Delphi, October 1993 and
1st Balkan Meeting of Human Genetics, Thessaloniki, September 1994.

33. Μichelakakis H., Dimitriou E., Tsagarakis S., Giouroukos S., Schulpis K. and
Bartsocas C.: Lysosomal Storage Diseases in Greece. 9th ESGLD Workshop,
Delphi, October 1993.

34. Michelakakis H., Papadopoulou V. and Papavasiliou A.: A case of Juvenile
Sandhoff Disease. 2nd Int. Duodecin Symposium Molecular Biology of Lysosomal
Diseases, Majvik Finland, May 1993.

35. Michelakakis H., Boot R., Dimitriou E., Verhoek M., Van Weely S., Mavridou I. and
Aerts H.: Genotypes of Greek Gaucher Patients. 1st EWGGD Workshop. Trieste,
October 1994.

36. Aerts J.M.F.G., Hollak C.E.M., Boot R.G., Renkema H., Verhoek M., Donker-
Koopman W., Strijland A., Van Weely S., Van Oers M.H.J., Erikson A. and
Michelakakis H. : Abnormalities in chitotriosidase in various Gaucher disease
phenotypes: A diagnostic marker. 1st EWGGD Worskshop, Trieste, October 1994.

37. Gyftodimou Y., Sarri C., Pandelia E., Petersen M.B., Pefanis AG, Michelakakis H.,
Bazopoulou-Kyrkanidou E.: A mentally and somatically retarded man with odd,
progeroid facies, trismus, blepharophimosis, macrotestis, articulo-skeletal
problems, reccurent pericarditis, diabetes mellitus and nephrosis – a new idiopathic
MCA/MR syndrome. 27th Annual Meeting European Society on Human Genetics,
Berlin, May 1995.

38. Burns S.P., Michelakakis H., Kordoni V., Iles R.A. and Chalmers R.A.: Diagnosis
and study of trimethylaminuria using proton magnetic resonance spectroscopy:
simultaneous quantitative measurement of methylamines, trimethylamine – N -oxide
and other metabolites in single analysis. 33rd Annual SSIEM Symposium, Toledo,
September 1995.

39. Shaag A., Anikster Y., Christensen E., Glustein J.Z., Fois A., Michelakakis H.,
Nigro F., Pronicka E., Ribes A., Zabot M.T., Elpeleg O.N.: The molecular basis of
aspartoacylase deficiency in European non-Jewish patients. 33rd Annual SSIEM
Symposium Toledo, September 1995. and 45 th Annual Meeting Amer. Soc. Hum.
Genet. Minneapolis, October 1995.

40. Anikster Y., Shaag A., Christensen E., Glustein J. Z., Fois A., Michelakakis H.,
Nigro F., Pronicka E., Ribes A., Zabot, M. T., Elpeleg O. N. : The molecular basis of
Canavan disease in European non-Jewish patients. Amer. Ped. Soc. and Soc.
Ped. Res. Meeting, San Diego, May 1995.

41. Michelakakis H., Spanou K., Kondyli A., Dimitriou E., Van Weely S., Hollak C.,
Van Oers E., Aerts H.: TNF-a plasma levels in Gaucher and other lysosomal
storage diseases. 10th ESGLD Workshop, Cambridge, September 1995.

42. Michelakakis H., Schutgens R.B.H., Moraitou M., Giftodimou G., Doulgeraki C.
and Wanders R.: Peroxisomal β-oxidation defect associated with enlarged catalase
positive organelles in fibroblasts from a neonate. 33rd Annual SSIEM Symposium,
September 1996.

43. Schulpis K.H., Papakonstantinou E.D., Michelakakis H.: Classical galactosemia
among 199.642 screened newborns in Greece. 4th Asian-European Workshop on
Inborn Errors of Metabolism, Germany, August 1996.

44. Holmes C. H., Burns P.S, Michelakakis H., Chalmers A. R. and Iles A. R.: Choline
and L-carnitine as precursors of trimethylamine. Biochemical Society Meeting No.
659, London, September 1996.

45. Hansen G.M., Riise H.M., Berg. T., Malm D., Michelakakis H., Neou P, Bartsocas
C., Tollersrud O.K. and Nilssen O.: The genetic, biochemical and clinical
characteristics of a Greek patient with α-mannosidosis. 7th International Congress
of Inborn Errors of Metabolism, Austria, May 1997.

46. Zafeiriou D., Anastasiou Al., Michelakakis H., Augoustidou-Savvopoulou P. Katzos
G., Kontopoulos EE.: Early- Infantile Krabbe disease: Deceptively normal magnetic
resonance imaging and serial neurophysiological studies. 7th International
Congress of Inborn Errors of Metabolism, Austria, May 1997.

47. Michelakakis H., Wanders R.J.A., Schutgens R.B.H., Moraitou M., Megaloyanni
E., Kourakis G., Dellagrammaticas H.: Isolated peroxisomal β-oxidation defect in a
neonate. 7th International Congress of Inborn Errors of Metabolism, Austria, May
1997.

48. Milos I., Jauk B, Hofler G., Levade T., Michelakakis H., Kleijer W. and Paschke E.:
Further evidence that mutation W273L is common for the phenotype of Morquio
disease type B. 7th International Congress of Inborn Errors of Metabolism, Austria,
May 1997.

49. Sakarelou N., Kosmaidou Z., Mesogitis S., Kallergis G., Prapa Z., Lyberatou E.,
Dimitriou E., Michelakakis H.: Gaucher’s disease Type I and pregnancy. 1st
European Cytogenetics Conference, Athens, June 1997.

50. Marinakis Th., Repa C., Kokkinou St., Christomanou H., Antypa H., Lymperopoulos
C., Michailides Arg., Michelakakis H.: Aglucerase injection is an efficient therapy
for type 1 Gaucher’s disease: the Greek experience. XIVth Meeting of the
International Society of Haematology, Sweden, August-September 1997.

51. Mavridou I., Dimitriou E., and Michelakakis H.: Response to sucrose loading in
mucolipidosis II and III. 11th ESGLD Workshop Bad Deutsch-Altenburg, September
1997.

52. Michelakakis H., Schutgens R.B.H., Moraitou M., Mavridou I., Dimitriou E. and
Wanders R.J.A.: Peroxisomal leukodystrophies in Greece. 11th ESGLD Workshop,
Bad Deutsch – Altenburg, September 1997.

53. Moraitou M., Dimitriou E. and Michelakakis H.: Iron load and chitotriosidase
activity in rat tissues. 2nd EWGGD Workshop, Maastricht, May 1997.

54. Marinakis Th., Repa C., Kokkinou S., Christomanou H., Antypa H., Lymperopoulos
C., Theodoropoulos B., Michailides A. and Michelakakis H.: Aglucerase therapy
for Gaucher’s disease. Preliminary results in Greek patients. 2nd EWGGD,
Workshop, Maastricht, May 1997.

55. Moraitou M., Wanders R.J.A., Schutgens RBH, Dimitriou E., and Michelakakis H.:
Laboratory investigation of peroxisomal leukodystrophies. 5th Meeting of the
Balkan Clinical Laboratory Federation, Ioannina, October 1997.

56. Dimitriou E., Moraitou M., and Michelakakis H.: Diagnostic significance of plasma
chitotriosidase levels. 5th Meeting of the Balkan Clinical Laboratory Federation,
Ioannina, October 1997.

57. Gyftodimou J., Michelakakis H., Sarri K., Petersen M.B.: Facial features
reminiscent of Kabuki syndrome with normal psychomotor and somatic
development. 8 th European Meeting on Dysmorphology, Strasburg, September
1997.

58. Labadaridis J., Dimitriou E., Costalos Ch, Aerts J., Van Weely S. and Michelakakis
H. : Serial Chitotriosidase Estimations in Neonatal Systemic Candidiasis. XVI
European Congress of Perinatal Medicine, Zagreb, June, 1998.

59. Tsolas G., Labadaridis J., Maire I., Michelakakis H, Avlonitis S., Schulpis K. and
Karis Ch.: DNA Analysis and Pedigree Study in a Greek Case of Glycogen Storage
Disease Ia. International Congress of Pediatrics, Amsterdam, August 1998.

60. Michelakakis H.: The Study of Inherited Metabolic Diseases in Greece. 3rd Balkan
Meeting on Human Genetics, Thessaloniki, August 1998.

61. Michelakakis H., Labadaridis J., Dellagrammaticas D., Gyftodimou Y., Moraitou
M., Wanders R., Schutgens R.: Early onset peroxisomal disorders: Clinical and
biochemical phenotypes in three cases. 36th SSIEM Annual Symposium, York,
September 1998.

62. Papavasiliou S., Sgouromalli U., Stamouli V., Paraskevoulakos V., Bazigou H.,
Michelakakis H.: Neurometabolic testing in developmental delay. 8th International
Child Neurology Congress, Ljubljana, September 1998.

63. Zafeiriou D., Kontopoulos E., Michelakakis H., Anastasiou A., Gombakis N. and
Katzos G.: Serial neurophysiological studies and magnetic resonance imaging in
late-infantile metachromatic leukodystrophy. 8th International Child Neurology
Congress, Ljubljana, September 1998.

64. Iles RA, Murphy HC, Hoomes HC, Dolphin CT, Michelakakis H, Phillips IR,
Shephard EA and Chalmers RA: Diagnosis and therapeutic monitoring using NMR
spectroscopy. 1st International Workshop on Trimethylaminuria NIH, USA, March
1999.

65. Michelakakis H, Moraitou M, Stamoulakatou A, Premetis V, Marinakis Th., Spanou
K., Kolaitis N: Plasmalogen levels in Gaucher disease patients. 3rd EWGGD
Workshop, Lemnos, May 1999.

66. Michelakakis H, Labadaridis J, Dimitriou E, Karis Ch., Marinakis Th., Charokopos
E, Papanikolaou Th, Liakopoulou Th, Syriopoulou V.: Diagnostic Significance of
Chitotriosidase Levels. 3rd EWGGD Workshop, Lemnos May 1999.

67. Marinakis Th., Repa C., Antypa H., Aliferopoulou M., Kokkinou St., Lymperopoulos
C., Theodoropoulos B., Michelakakis H., Michailides A.: Enzyme replacement
therapy for Gaucher’s disease in Greek adult patients: A four years experience. 3rd
EWGGD Workshop, Lemnos, May 1999.

68. Michelakakis H, Beesley C, Moraitou M, Young E, Mavridou I, Winchester B:
Sanfilippo B Disease, Mutations in Greek Patients. 37th SSIEM Annual
Symposium, Genova, September 1999.

69. Michelakakis H, Hermans MMP, Van Leenen D, Mavridou I, Laskari H, Kourkouli
M, and Reuser AJJ: Pompe’s disease. New mutation in a Greek infant.12th ESGLD
Workshop, Vidago-Portugal, September 1999.

70. Mavridou I, Charocopos E, Komianou F, Young L, Jackson M and Michelakakis
H.: Clinical and Biochemical findings in two patients with juvenile galactosialidosis.
12th ESGLD Workshop, Vidago – Portugal,September 1999.

71. Schulpis K., Papakonstantinou E., Shin Y., Michelakakis H. and Mengrelli C.: Pilot
screening for disorders of galactose metabolism in Greece. 4th Meeting of the
International Society for Neonatal Screening, Stockholm, June 1999.

72. Monastirli A., Cariolou M., Michelakakis H., Pasmatzi E., Sakkis Th., Badavanis
G., Georgiou S., Tsambaos D.: Severe from of Anderson-Fabry disease associated
with a new trinucleotide deletion and diffuse facial teleangiectases. 14 th Regional
Conference of Dermatology (Asian – Australasian). Kuala Lumpur, Malaysia, July
2000.

73. Michelakakis H, Moraitou M, Van Weely S, Verhoek M, Aerts H. The facile
detection of R463Q (IVS10-1) mutation in Greek Gaucher disease patients. VIII
International Congress of Inborn Errors of Metabolism, Cambridge, September
2000.

74. Iles RA, Murphy HC, Dolphin CT, Janmohamed A, Holmes JC, Michelakakis H,
Shephard EA, Chalmers RA, Phillips IR.: Characterization and Enzyme Expression
Analysis of FMO3 Mutations in Trimethylaminuria Using Proton NMR Spectroscopy.
VIII International Congress of Inborn Errors of Metabolism, Cambridge, September
2000.

75. Moraitou M, Elpeleg O, Papadakis M, Shaag A, Balassopoulou A, Papapanayotou
E, Michelakakis H.: Prenatal diagnosis of Canavan disease by DNA analysis. 41st
Annual Meeting, ESPR, Rhodes, September 2000.

76. Labadaridis J, Karis Ch, Moraitou M, Theodoraki M, Nikolaidou A, Zossi P,
Michelakakis H.: Plasmalogen levels in neonates. 41st Annual Meeting, ESPR,
Rhodes, September 2000.

77. Labadaridis J., Velegraki A., Dimitriou E., Theodoraki M., Hiza A., Mirmiri D. and
Michelakakis H. : Aspergillus Niger in two VLBW neonates. XVII European
Congress of Perinatal Medicine, Porto, June 2000.

78. Michelakakis H., Skardoutsou A.G., Mathioudakis J., Moraitou M, Dimitriou E.,
Voudris C., Karpathios Th.: Severe Neurological Involvement and D409H
Homozygosity in a Greek Patient. Outcome of ERT. 2 nd International Conference of
Prospects in the Treatment of rare Diseases, Trieste, May 2001 and 1st
International Symposium on Lysosomal Storage Diseases, Seville, April 2001.

79. Maropoulos G., Zaferiou D., Skardoutsou A., Sulpi K., Katsarou E., Augoustides-
Savopoulou P., Michelakakis H., Evaggeliou T., Papadreou O., Drogari E.:
Organic Acids Disorders with Neurological Manifestation. 39 th Annual Symposium
SSIEM, Prague, September 2001.

80. Michelakakis H., Zafeiriou D., Moraitou M., Goutjes J., Vreken P., Wanders R.:
PEX1 Deficiency Misdiagnosed as Leber’s Congenital Amaurosis. 39 th Annual
Symposium SSIEM, Prague, September 2001.

81. Dimitriou E., Moraitou M., Troungos C., Schulpis K. and Michelakakis H.: Gaucher
disease: Frequency of the N370S mutation in the Greek population. 13 th Workshop
ESGLD, The Netherlands, September 2001.

82. Paschke E., Milos I., Hofler G, Kleijer W., Beck M., Michelakakis H., Levade T and
Hoeltzenbein M.: The Pathogenesis of Mucopolysaccharidosis Type IV B and Adult
GM 1- Gangliosidosis. 13 th Workshop ESGLD, The Netherlands, September 2001.

83. Labadaridis I., Dimitriou E., Theodoraki M., Mermiri D., Sawaqed V., Velegraki
A.and Michelakakis H.: Chitotriosidase in neonatal fungal infections. 5 th World
Congress of Perinatal Medicine, Barcelona, September 2001.

84. Voudris K., Skardoutsou A, Bonou P., Katsaloulis M., Vagiakou E., Katsarou E.,
Mavromatis P, Michelakakis E.: Chronic Infantile type of fucosidosis: The first
report from Greece. 7 th Mediterranean Epilepsy Conference, Athens, November
2001,

85. Voudris K., Skardoutsou A., Vagiakou E., Katsaloulis M., Katsarou E., Mavromati
P., Michelakakis E.: An unusual case of Gaucher Disease of Childhood. 7 th
Mediterranean Epilepsy Conference, Athens, Greece, November 2001.

86. Marinakis Th., Repa C., Tsaftaridis P., Fakithari H., Michelakakis H., Kammas A.:
Enzyme replacement therapy for Gaucher disease in Greek adult patients: a seven
years experience. 5 th Workshop of the European Working Group on Gaucher
Disease, Prague, May 2002.

87. Labadaridis I., Moraitou M., Theodoraki M., Dimitriou E., Nikolaidou A., Saouakit J.,
Sarafidou J. and Michelakakis H. Plasmalogen and malondialdehyde levels in full
term neonates. XVIII European Congress of Perinatal Medicine, Oslo, June 2002.
88. Zafeiriou D.I., Triantafyllou P., Gombakis N, Vargiami E., Tsantali C., Michelakakis
E., Vanier M. Niemann-Pick Type C Disease Associated with Peripheral
Neuropathy. 28th Annual Meeting of the Society for Neuropediatrics, 2002.

89. Labararidis I.A., Moraitou M., Theodoraki M., Dimitriou E, Kafalidis G.,Karamatzanis J., Sarafidou J., Michelakakis H. Plasmalogen and malondialdehyde
levels in full term stressed and non stressed neonates. Peroxisomal Disorders and
Regulation of Genes, Ghent, September 2002.

90. Labadaridis I., Theodoraki M., Dimitriou E., Savala M., Velegraki A., Sawaqed
U.,Krali M, Michelakakis H. Chitotriosidase levels in neonatal infections. 21st
Annual Meeting of the European Society for Paediatric Infectious Diseases, Sicily,
April 2003.

91. Beesley C.E., Moraitou M., Winchester B., Schulpis K., Dimitriou E., Michelakakis
H. Sanfilippo B in Greece. 14 th ESGLD Workshop, Podebrady, September 2003.

92. Lugowska A., Tylki-Szymanska A., Amaral O., Berger J., Berna L., Bosshard N.U.,
Fensom A., Lissens W., Marcao A., Michelakakis H., Molzer B., Regis S., Sinke
R.J., Czartoryska B. Prevalence of 459+1G>A and P426L mutations in
Metachromatic leukodystrophy-patients from some European countries. 14 th
ESGLD Workshop, Podebrady, September 2003.

93. Linthorst G.E., Iatrou Ch., Moraitou M., Zorbas S., Mavridou I., Aerts J.M.F.G.,
Michelakakis H. Fabry’s disease: A new mutation in a Greek family. 14 th ESGLD
Workshop, Podebrady, September 2003.

94. Labadaridis I, Theodoraki M, Karigianni E, Papassotiriou I, Michelakakis H. S-
100B in human milk the first week after birth. The 6 th World Congress of Perinatal
Medicine, Osaka September 2003.

95. Fotoulaki M, Michelakakis H, Augoustides-Savvopoulou P, Simonaro CM,
Mavridou I, Nousia-Arvanitakis, Schuchman E. Niemann-Pick Disease Type B: A
novel mutation in a Greek child. Annual Symposium on Lyososomal Storage
Disorders, Madrid, April 2004.

96. Michelalakis H., Kariyannis C., Moraitou M., Dimitriou E., Sarafidou J.,
Papassotiriou I. Serum S-100B levels in X-ALD and Gaucher Disease. SSIEM 41 st
Annual Symposium, Amsterdam, 31 August-3 September 2004.

97. Augoustides-Savvopoulou P., Kambouridou P., Michelakakis H., Kozeis N.,
Tsepkentzis K., Papadopoulos F. : Pseudotumor Cerebri as a presenting symptom
in a neonate with classical galactosemia. SSIEM 41 st Annual Symposium,
Amsterdam, 31 August-3 September 2004.

98. Labadaridis I., Moraitou M., Theodoraki M., Konstandinidou E., Sarafidou J.,
Michelakakis H.: A-Linoleic and Arachidonic acid in perinatal anoxia and
prematurity. XIX European Congress of Perinatal Medicine, Athens, October 2004.

99. Marinakis Th., Repa C., Karkalousos, Michelakakis H. Extended interval between
enzyme therapy infusions for adult patients with Gaucher’s disease type 1. 6 th
European Working Group on Gaucher Disease, Barcelona, October 2004.

100. Marinakis Th., Repa C., Karkalousos P., Tsaftaridis P., Symeonidis A., Kammas A.,
Michelakakis H. Treatment of Gaucher’s disease in Greek adult patients : initial
long term analysis of a collaborative study of enzyme replacement therapy. 6 th
European Working Group of Gaucher Disease, Brcelona, October 2004.

101. Michelakakis H., Dimitriou E., Labadaridis I. The expanding spectrum of disorders
with elevated plasma chitotriosidase activity: an update. 6 th European Working Group
on Gaucher Disease, Barcelona, October 2004.

102. Labadaridis I., Dimitriou E., Theodorakis M., Savala M., Kafalidis G., Velegraki A.,
Michelakakis H. Chitotriosidase Levels in Neonatal Infections. 6 th European Working
Group on Gaucher Disease, Barcelona, October 2004.

103. Dasopoulou M.D., Michelakakis E.M., Baroutis G.D., Loukatou E.G., Covanis A.P.,
Apostolou M.A., Petrou A.S., Tserga O.N., Costalos C.J. Early Onset Severe
Neonatal Phenotype and D409H Homozygosity in Gaucher Disease.2 nd
Mediterranean Congress of Neurology, Nicosia, April 2004.

104. Dasopoulou M.D., Baroutis G.D., Loukatou E.G., Papathoma E.T., Apostolou M.A.,
Michelakakis E.M., Petrou A.S., Tserga O.N., Costalos C.J. Lethal Congenital
Varicella Syndrome; Unusual Neonatal Presentation. 2 nd Mediterranean Congress of
Neurology, Nicosia, April 2004.

105. Dasopoulou M.D., Baroutis G.D., Loukatou E.G., Apostolou M.A., Michelakakis
E.M., Petrou A.S., Tserga O.N., Costalos C.J. Unusual Fatal Neonatal Herpes
Infection. 2 nd Mediterranean Congress of Neurology, Nicosia, April 2004.

106. Gombakis N., Vargiami E., Michelakakis E., Dimitriou E., Moraitou M., Athanasiou-
Metaxa M., Zafeiriou DI. Efficacy of Enzyme Replacement Therapy in Patients with
Gaucher Disease. 2 nd Symposium on Lysosomal Storage Disorders, Athens, March
2005.

107. Gombakis N., Vargiami E., Michelakakis E., Dimitriou E., Moraitou M. Stamouli K.,
Tsantali C., Athanasiou-Metaxa M., Zafeiriou DI. Gaucher Disease: Report of 5
cases. 2 nd Symposium on Lysosomal Storage Disorders, Athens, March 2005.

108. Moraitou M., Dimitriou E., Michelakakis H. Looking for CDG defects in Greece. First
Euroglycanet Meeting, Athens, March 2005.

109. Tsakiris S., Michelakakis H., Tsakiris T. and Schulpis K.H. Low total antioxidant
status is implicated with degradation of erythrocyte membrane protein content in
patients with classical galactosaemia. FEBS – IUBMB Conference, Budapest, July
2005.

110. Michelakakis H., Kroos M., Reuser A., Mavridou I., Manta P. Pompe Disease in
Greece: A study of juvenile and adult cases. SSIEM 42st Annual Symposium, Paris,
September 2005.

111. Labadaridis J., Theodoraki M., Dimitriou E., Spanou K, Sarafidou J, Triantaphyllidis
G., Michelakakis H. Chitotriodisase activity and IL-10 levels in neonatal infections.
46 th meeting European Society for Pediatric Research, Sienna, August 2005.

112. Labadaridis J, Theodoraki M, Kariyanni C, Sarafidou J, Kafalidis G, Thriantafyllidis G,
Papassotiriou J, Michelakakis H. S-100B Levels in Maternal Milk and Modified
Infant and Preterm Formulae. 29 th Umemps Congress, Union of Middle Eastern and
Mediterranean pediatric societies, Instabul, September 2005.

113. Michelakakis H., Moraitou M., Dimitriou E, Santamaria R., Sanchez G., Chabas A.,
Grinberg D. and Vilageliou L. D409 and H255Q homozygosity in type II Gaucher
disease patients. 15 th ESGLD Workshop, Oslo, September 2005.

114. Dimitriou E., Verhoek M., Altun S., Youssef J., Karabatsos F., Boot R., Sarafidou J.,
Karagiorga M., Aerts H., Michelakakis H. Plasma PARC levels in patients with β-
thalassemia major. 15 th ESGLD Workshop, Oslo, September 2005.

115. Garipidou V., Vakalopoulou S., Michelakaki E., Leukou E., Perifanis V. Type 1
Gaucher Disease presenting as an asymptomatic disorder in two Greek Adult
patients. 3 rd Symposium on Lysosomal Storage Disorders, 25 Years of Innovation in
the field of Lysosomal Storage Disorders. Berlin, April 2006.

116. Lianou D., Poulopoulos P, Mavridou I, Kotsonis K., Kassiou K. Michelakakis H.
Infantile Pompe disease – successful short-term results of enzyme replacement
therapy (ERT) . International Symposium, Steps Forward in Pompe Disease, Berlin,
April 2006.

117. Tsina E., Koidou A., Lianou D., Michelakakis H., Mavridou I., Reuser A., Krooss M.,
Paikos P. Night Blindness Due to Juvenile Pompe’s Disease (Type II Glycogenosis).
ARVO Annual Meeting, Florida, April 30- May 4, 2006.

118. Tsekoura E., Panousopoulou C., Michelakakis H., Brown G.K., Anagnostakou M.
Fetal Brain MRI Findings in two cases of pyruvate dehydrogenase deficiency. XX
European Congress of Perinatal and Neonatal Medicine, Prague, May 2006.

119. Siahanidou T., Michelakakis H., Jacobs C., Verhoeven N., Acquaviva C., Mandyla
H. Molybdenum cofactor deficiency in a neonate. XX European Congress of
Perinatal and Neonatal Medicine, Prague, May 2006.

120. Michelakakis H, Dimitriou E, Mavridou I, Tsagarakis S. Mucolysaccharidoses in
Greece. 9 th International Symposium on Mucopolysaccharide and Related Diseases,
Venezia, June 29-July 2, 2006.

121. Niktari G, Skiadas C, Vanier MT, Xini K, Dimitriou E, Mavridou I, Michelakakis H.
“Oral substrate reduction therapy with miglustat in an infantile case of Niemann-Pick
disease type C”. 7 th EWGGD Workshop, Cambridge, July 2006.

122. Labadaridis I, Theodoraki M, Dimitriou E, Spanou K, Sarafidou J, Triantaphyllidis G,
Michelakakis H. “Chitotriosidase activity and IL-10 levels in neonatal infections”. 7 th
EWGGD Workshop, Cambridge, July 2006.

123. Lianou D, Syrengelas D, Poulopoulos P, Klimentopoulou A, Mavridou I,
Michelakakis H. “Early signs of benefit in a child with late-onset Pompe disease
following treatment with enzyme replacement therapy”. 4 th Symposium on Lysosomal
Storage Disorders, Vienna, March 2007.

124. Gombakis N, Vargiami E, Michelakakis E, Dimitriou E, Moraitou M, Tsantili C,
Athanasiou-Metaxa M, Zafeiriou DI. Gaucher disease and enzyme replacement
therapy in patients of northern Greece. 4 th Symposium on Lysosomal Storage
Disorders, Vienna, March 2007.

125. Michelakakis H, Mavridou I, Schuchman E, Manolaki N, Priftis K, Hatzistylianou M,
Pavlou E, Moshou V. Acid sphingomyelinase deficiency: phenotypes of patients
homozygous for W319G. 4 th Symposium on Lysosomal Storage Disorders, Vienna,
March 2007.

126. Papasilekas T, Moraitou M, Michelakakis E, Stefanis L. Alpha-synuclein levels in
Gaucher disease. 17 th Meeting of the European Neurological Society, Rhodes, June
2007.

127. Lianou D, Klimentopoulou A., Poulopoulos P, Syreangelas D. Mavridou I,
Michelakakis H. Pomple disease: Clinical follow-up of two patients on enzyme
replacement therapy (ERT). 25 th International Congress of Pediatrics “for the health
and well-being of our children”, Athens, August 2007.

128. Drogari E, Michelakaki E, Stamboulidis K, Drossatou P, Drakou Ch.
Methylprednisolone pulse therapy in lysinuric protein intolarance and early interstitial
lung disease, a case report. 25 th International Congress of Pediatrics for the health
and well-being of our children”, Athens, August 2007.

129. Michelakakis H, Moraitou M, Dimitriou E, Reppa C, Zafeiriou D, Marinakis T,
Sarafidou J. Red blood cell plasmalogen levels in Gaucher disease, the effect ofERT. SSIEM, Annual Symposium, Society for the Study of Inborn Errors of
Metabolism, Hamburg, September 2007.

130. Caciotti A, Donati MA, Carraresi L, Cavicchi C, Filocamo M, Di Rocco M,
Michelakakis H, Mavridou I, Zammarchi E, Guerrini R, Morrone A. Clinical and
Molecular Findings of Sialidosis Patients with Different Phenotypes. SSIEM, Annual
Symposium, Society for the Study of Inborn Errors of Metabolism, Hamburg,
September 2007.

131. Lianou D, Syrengelas D, Andreou N, Klimentopoulou A, Poulopoulos P, Kapodistrias
K, Mavridou I, Michelakakis H. Enzyme replacement therapy (ERT) for Pompe
disease: the Greek experience in children. SSIEM, Annual Symposium, Society for
the Study of Inborn Errors of Metabolism, Hamburg, September 2007.

132. Hrebicek M, Mrazona L, Majewski J, Morgan Ken, Seyrantepe V, Durand S, Noskova
L, Hartmannova H, Ivanek R, Cizkova A, Poupetova H, Sikora J, Urinovska J,
Stranecky V, Michelakakis H, Stuke-Sontheimer A, Steinfelf R, Zeman J,
Pshezhetsky A and Kmoch S. Mutations in TMEM76 are associated with acetyl
coenzyme A: α-glucosaminie N-acetyltransferase deficiency in MPS III C (Sanfilippo
C) patients: an update. 16 th ESGLD Workshop, Perugia, Septermber 2007

133. Michelakakis H, Kroos M, Lourida A, Mavridou I, Reuser A. Classic Infantile Pompe
Disease: A novel mutation. 16 th ESGLD Workshop, Perugia, Septermber 2007

134. Lianou D, Syrengelas S, Poulopoulos P, Kotsonis K, Klimentopoulou A, Mavridou I,
Michelakakis H. Pompe disease: early signs of benefit in a child with late-onset form
following treatment with enzyme replacement therapy (ERT). 7 th European Paediatric
Neurology Society, EPNS Congress, Kusadasi, September 2007.

135. Mavridou I, Moraitou M, and Michelakakis H. Lysosomal enzyme activities in CDGI,
CDGII, galactosemia and fructosemia. 3 rd International Meeting on Congenital
Disorders of Glycosylation, Paris, October 2007 and SSIEM Annual Symposium,
Lisboa, Septermber, 2008.

136. Lianou D, Syrengelas D, Poulopoulos P, Roka K, Mavridou I, Michelakakis H.
Enzyme replacement therapy (ERT) in Pompe disease: an 18-month follow-up in a
child with the late-onset phenotype. 2 nd European Symposium Steps Forward in
Pompe Disease, November 2007

137. Sabourdy F, Michelakakis H, Garcia V, Mavridou I, Nieto M, Pons MC, Anastasakis
A, Stefanadis C, Levade T. Clinical and Molecular characterization of two Greek
cases of Danon disease (Lamp-2 deficiency). Fifth Symposium on Lysosomal
Storage Disorders,Paris,May 2007.

138. Moraitou M, Dimitriou E, Zafeiriou D, Reppa C, Marinakis T, Sarafidou J,
Michelakakis H. Plasmalogen levels in Gaucher disease. 8 th European Working
Group on Gaucher Disease Meeting, Budapest, June 2008.

139. Xaidara A, Karavitakis E, Kosma K, Dimitriou E, Michelakakis H. Chitotriosidase
levels in cystinosis. SSEIM Annual Sumposium, Lisboa, September, 2008.

140. Labadaridis I, Moraitou M, Gyftodimou Y, Dellagramaticas H, Triantafyllidis G,
Wanders R, Michelakakis H. Peroxisomal disorders of the neonatal period. XXI
European Congress of Perinatal Medicine, Istanbul, September 2008.
141. Antoniou X, Michelakakis E, Roussohatzaki M, Ioannidis D, Papavasilliou A.Hyperprolinemia type II. Case report. New Horizons in Pediatric Neurology,
Neurosurgery and Neurofibromatosis, Eilatn, Israel, March 2009.

142. Michelakakis H, Dimitriou E, Moraitou M, Valari M, Talanti V, Mitsiadi V, M. Cozar,
Vilageliu L, Grinberg D, Karachristou K. “Perinatal lethal form of Gaucher disease.
Clinical and molecular characterization of a Greek case”. 17 th ESGLD Workshop,
Βad Honnef/Germany, Septermber 2009.

143. Dimitriou E, Mavridou I, Manta P, Lianou D, Zafeiriou D, Labadaridis I, Michelakakis
H. “Alternative methods for the laboratory diagnosis of Pompe disease”. 17 th ESGLD
Workshop, Βad Honnef/Germany, Septermber 2009.

144. Zafeiriou DI, Vargiami E, Anastasiou A, Ververi A, Michelakakis E, Gombakis N.
“Gaucher disease type III with craniosynosteosis” 8 th Congress of the European
Paediatric Society, U.K., September 2009.

145. Lianou D, Syrengelas D, Garatzioti M, Akritidou I, Brokolaki M, Michelakakis H.
“Pompe Disease: a spectrum of phenotypes. Effect of enzyme replacement therapy
(ERT). 8 th Congress of the European Paediatric Society, U.K., September 2009.

146. Lianou-Trapezanoglou D, Garatzioti M, Syrengelas D, Mavridi I, Michelakakis H.
“Severe and recurrent infusion-associated reactions (IARs) in a patient with infantile-
onset Pompe disease”. 3 rd European Symposium Steps Forward in Pompe Disease,
November 2009, Germany.

147. Michelakakis H, Lianou D, Kroos M, Mavridou I, Dimitriou E, Akritidou I, Syrengelas
D, Reuser A. “Late onset Pompe Disease: novel mutations and response to Enzyme
Replacement Therapy (ERT)”. Biochemical Society Conferences “Lysosomes in
Health & Disease”, May 2010, London, U.K.

148. Labadaridis I, Moraitou M, Dimitriou E, Konstadinidou C, Triantafyllidis G, Monopolis
I, Michelakakis H. “Investigation of oxidative stress in neonates”. XXII European
Congress of Perinatal Medicine, May 2010, Granada, Spain.

149. Michelakakis H., Dimitriou E., Mavridou I., Georgouli H., Ploski R., Pollak
A.,Moraitou M. “Transferrin Isoelectric Focusing and Plasma Lysosomal Enzyme
Activities in the Diagnosis and Follow up of Fructosemia”. Annual Symposium of the
Society for the Study of Inborn Errors of Metabolism, September 2010, Istanbul,
Turkey.

150. Gallego L., Lianou D., Michelakakis H., Perez-Cerda C., Perez B., Ginis S., Jakobs
C., Ugarte M., Desviat LR. “Functional analysis of a novel PCCA mutation with partial
residual activity identified in a late-infantile onset propionic academia patient. Annual
Symposium of the Society for the Study of Inborn Errors of Metabolism, September
2010, Istanbul, Turkey.

151. Moraitou M., Xiromerisiou G., Dardiotis E., Kountra P.S., Gourbali V. I., Stefanis
L., Hadjigeorgiou G. and Michelakakis H. “GBA Mutations and Parkinson’s
Disease”. 9 th International EWGGD Workshop, July 2010, Cologne, Germany.

152. Dimitriou E., Moraitou M., Troungos C., Schulpis K. and Michelakakis H. “The
frequency of the N370S mutation in the Greek population”. 9 th International EWGGD
Workshop. July 2010, Cologne, Germany

153. Moraitou M., Hatzigeorgiou G., Monopolis I., Dardiotis E., Bozi M., Vassilatis D.,
Villageliu L., Grinberg D., Xiromerisiou G., Stefanis L., Michelakakis H. “β-
Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic
Parkinson’s didease”. Annual Symposium of the Society for the Study of Inborn
Errors of Metabolism, August 2011,.

154. Komninaka V., Kolomodi D., Mitropoulou M., Marinakis T. Repa K., Michelakakis H.,
Voskaridou E., Chrostoulas D., Terpos E., “Evaluation of bone marrow involvement
using a semi-quantitative magnetic resonance imaging methods in patients with non-
neuropathic Gaucher diseases”. European Working Group of Gaucher Disease
Meeting, June 2012,.

155. Moraitou M., Dimitriou E., Dekker N., Monopolis I., Aerts H., Michelakakis H.
“Plasmalogen levels and Gaucher disease” Further studies”. European Working
Group of Gaucher Disease Meeting, 2012,

156. Dimitriou E., Moraitou M., Koutouzis E., Lianou D., Syriopoylou V., Michelakakis H.
“Chitotriosidase in Leishmania infection”. Eurpean Working Group of Gaucher
Disease Meeting, 2012,.

157. Komninaka V., Marinakis T., Christoulas D., Repa K., Kolomodi D., Mitropoulou M.,
Gkotzamanidou M., Papatheodorou A., Michelakakis H., Voskaridou E., Dimopoulos
MA., Perpos E. “Increased bone resorption due to high serum C-C motifi Ligand-2
(CCL-3) in present in patients with non-neuronopathic Gaucher Disease”. European
Working Group of Gaucher Disease Meeting. 2012

158. Diaz L., Serra J., Sanchez-Olle G., Grinberg D., Michelakakis H., Mavridou I.,
Delgado A., Bujons J., Casas J., Vilageliu L. “Chaperone effect of several products,
mostly aminocyclitols, on mutated GBAs form Gaucher patients’ fibroblasts”.
European Working Group of Gaucher Disease Meeting, June 2012, Paris, France.

159. Lianou D., Syrengelas D., Andreou N., Chantzopoulos I., Mavridou I., and
Michelakakis H. Pompe Disease (PD): clinical outcome in infants and children
treated with recombinant human acid alpha-glucosidase (rhgaa). 10th EPNS
Congress. 2013. Book of Abstracts (European Journal of Paediatric Neurology).

160. Mavridou I., Cozar M., Douzgou S., Xaidara A., Lianou D., Dimitriou E., Vanier M.T.,
Grinberg D., Vilageliu L., and Michelakakis H. Niemann Pick type C disease: A
novel NPC a greek island. 12th International Congress of Inborn Errors of
Metabolism. 2013. Journal of Inherited Metabolic Disorders. v. 36(Suppl1).

161. Sarra J., Diaz L., Gutierrez de Teran H., Sanchez-Olle G., Bujons J., Michelakakis
H., Delgado A., Grinberg D., Vilageliu L, and Casas J. chaperone effects of new
aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
12th International Congress of Inborn Errors of Metabolism. 2013. Journal of
Inherited Metabolic Disorders. v. 36(Suppl1).

162. Dimitriou E.; Mavridou I.; Cozar M.; Grinberg D.; Vilageliu L., and Michelakakis H. the
spectrum of Krabbe disease in Greece-Laboratory experience. SSIEM. Annual
Symposium of the Society for the Study of inborn errors of metabolism; 2015;
Journal of Inherited Metabolic Disorders. v. 38(Suppl1).

163. Moraitou M.; Dermentzaki G.; Dimitriou E.; Monopolis I.; Dekker N.; Aerts H.;
Stefanis L., and Michelakakis H. a-synuclein dimerization in erythrocytes of gaucher
disease patients in relation to lipid abnormalities and oxidative stress. European
Working Group on Gaucher Disease. 11th Meeting; 2014.

164. Serra-VInardell J.; Casas J.; Vilageliu L.; Michelakakis H.; Mavridou I.; Aerts J.;
Decrooco C.; Compain P.; Delgado P., and Grinberg D. glucocerebrosidase
enchancement in selected Gaucher disease fibroblasts by a series of DIX
compounds. European Human Genetics Conference; 2014. European Journal of
Human Genetics. v. 22(SUPPL1).

165. Pashali V; Dimitriou E.;Moraitou M; Kanariou M; Michelakakis H. Immune
irregularities in lysosomal storage disease patients. SSIEM. Annual Symposium of
the Society for the Study of inborn errors of metabolism; 2015; Journal of Inherited
Metabolic Disorders. v. 38(Suppl1).

166. Van Capelleci; Van der Meijden J C ;Van den Hout J MP; Jaeken J; Baethmann M ;
Voit T ; Kroos M A ; Van Sponsen F J ; Rubio-Gazalbo M E; Willemsen M ;
Lachmann R H ; Mengel E; Michelakakis H; Reuser A J J ; Van der Ploeg A T.
Childhood Pompe disease:clinical spectrum and genotype in 31 children. SSIEM.
Annual Symposium of the Society for the Study of inborn errors of metabolism; 2015;
Journal of Inherited Metabolic Disorders. v. 38(Suppl1).

167. Variami E; Papathanasiou E; Batzios S; Kyriazi M; Michelakakis H; Anastasiou A;
Sidira C; Giese A K;Zafeiriou D.Two further greek cases of Krabbe disease and a
new mutation in GALC gene. European Paediatric Neurology Society Congress;
2015; European Journal of Paediatric Neurology.v.19 (SUPPL1)

168. Jansen J., Timal S., Van Scherpenzeel M., Ashikov A., Jansen E., Wevers R.,
Huynen M., Michelakakis H., Moraitou M., Foulquier F., Veltman J., Stevens T., and
Lefeber D. A novel group of metabolic disorders due to tissue-specific defects in
VATPASE assembly. . SSIEM. Annual Symposium of the Society for the Study of
inborn errors of metabolism; 2016; Journal of Inherited Metabolic Disorders. v.
39(Suppl1).

169. Mavridou I., Dimitriou E., Vanier M., Vilageliu L., Grinberg D., Latour P., Xaidara A.,
Lycopoulou L., Bostantjopoulou S., Zafeiriou D., and Michelakakis H. The spectrum
of NIemann Pick type C disease in Greece. . SSIEM. Annual Symposium of the
Society for the Study of inborn errors of metabolism; 2016; Journal of Inherited
Metabolic Disorders. v. 39(Suppl1).

170. Repa C., Marinakis T, Kourakli A, Zafeiriou D, Tsaftaridis P,Michelakakis H,
Konminaka V, Pappa V, Roussou P, Vlachaki E,Kotsopoulou M, Makis A, Mandala
M, Voskaridou E, Anagnostopoulos N,Symeonidis. A Occurence of neoplastic
diseases and of preneoplastic conditions, among Greek patients with Gaucher
disease. . European Working Group on Gaucher Disease. 12th Meeting, Zaragosa
2016

171. Dimitriou E., Moraitou M., Vilageliu L., Grinberg D., Serra-Jose J., Cozar M.,
Mavridou M., Michelakakis H. Gaucher disease in Greece laboratory investigations.
European Working Group on Gaucher Disease. 12th Meeting, Zaragosa 2016

172. Georgiadou E., Papadakou H., Lefeber D., Van Tol W., Papadopoulos K., Moraitou
M., Papadimas G., Dimitriou E., and Michelakakis H. A New Dmp3-Cdg (Cdg-Io)
Greek Patient. A Hot Spot foo Inborn Errors Of Metabolism ; Athens, 2018. J Inherit
Metab Dis. V. 41(Suppl 1):S192-S193. 2018

173. Malekkou A., Sevastou I., Mavrikiou G., Georgiou T., Vilageliu L., Moraitou M.,
Michelakakis H., Prokopiou C., and Drousiotou A. A Novel Mutation Deep Within
Intron 7 Of The Gba Gene Causes Gaucher Disease . SSIEM. Annual Symposium of
the Society for the Study of Inborn Errors of Metabolism; Athens 2018. J Inherit
Metab Dis. v. 41(Suppl 1):S192. 2018

174. Moraitou M. Papagiannakis N. Dimitriou Ε. Mavridou I., Stefanis L., and
Michelakakis H. A-Synuclein Dimerization in Erythrocytes Of Patients and Carriers
of Sanfilippo Syndrome. SSIEM. Annual Symposium of the Society for the Study of
Inborn Errors Of Metabolism; Athens, Greece. J Inherit Metab Dis. v. 41(Suppl
1):S166. 2018

175. Moraitou M., Sotiroudis G., Dimitriou E., Papagiannakis N., Stefanis L., Xenakis A.
and Michelakakis H. Glucosylceramide Species In Red Blood Cell Membranes of
Gaucher Disease Patients . SSIEM. Annual Symposium of the Society for the Study
of Inborn Errors of Metabolism; Athens 2018. J Inherit Metab Dis. v. 41 (Suppl 1):
S168. 2018

176. Efstathiou Κ Α, Häberle J, Tatouli I P, Rüfenacht V , Papachatzakis I ,Michas F ,
Delavinia C, Mavridou I , Michelakakis H. Citrullinemia type II (CTLN2) : A novel mutation in the first Greek case. SSIEM. Annual Symposium of the Society for the
Study of Inborn Errors Of Metabolism; Athens 2018

177. Moraitou M,Papagianakis N, Dimitriou E, Stefanis L, Michelakakis H: Alpha-
Synuclein dimerization in erythrocytes of Gaucher disease carriers and patients
before and after enzyme replacement therapy. SSIEM. Annual Symposium of the
Society for the Study of Inborn Errors of Metabolism; Rotterdam 2019

178. Moraitou M, Lefeber D, Ashikov A, AbuBakar N, Jaeken J, Michelakakis H:
Experience with congenital disorders of glycosylation in Greece. SSIEM. Annual
Symposium of the Society for the Study of Inborn Errors of Metabolism; Rotterdam
2019

179. Moraitou M., Sotiroudis G., Dimitriou E., Papagiannakis N., Stefanis L., Xenakis A.
and Michelakakis H. Glucosylceramide Species In Red Blood Cell Membranes of
Gaucher Disease Patients and Carriers. European Working Group on Gaucher
Disease. 13th Meeting, Clermont-Ferrand ,2019.